276 related articles for article (PubMed ID: 23933322)
21. SETDB1 modulates PRC2 activity at developmental genes independently of H3K9 trimethylation in mouse ES cells.
Fei Q; Yang X; Jiang H; Wang Q; Yu Y; Yu Y; Yi W; Zhou S; Chen T; Lu C; Atadja P; Liu XS; Li E; Zhang Y; Shou J
Genome Res; 2015 Sep; 25(9):1325-35. PubMed ID: 26160163
[TBL] [Abstract][Full Text] [Related]
22. 3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation.
Fujiwara T; Saitoh H; Inoue A; Kobayashi M; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Harigae H
J Biol Chem; 2014 Mar; 289(12):8121-34. PubMed ID: 24492606
[TBL] [Abstract][Full Text] [Related]
23. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells.
Chiba T; Suzuki E; Negishi M; Saraya A; Miyagi S; Konuma T; Tanaka S; Tada M; Kanai F; Imazeki F; Iwama A; Yokosuka O
Int J Cancer; 2012 Jun; 130(11):2557-67. PubMed ID: 21717453
[TBL] [Abstract][Full Text] [Related]
24. 3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death.
Tam EK; Nguyen TM; Lim CZ; Lee PL; Li Z; Jiang X; Santhanakrishnan S; Tan TW; Goh YL; Wong SY; Yang H; Ong EH; Hill J; Yu Q; Chai CL
ChemMedChem; 2015 Jan; 10(1):173-82. PubMed ID: 25319940
[TBL] [Abstract][Full Text] [Related]
25. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.
Zhou J; Bi C; Cheong LL; Mahara S; Liu SC; Tay KG; Koh TL; Yu Q; Chng WJ
Blood; 2011 Sep; 118(10):2830-9. PubMed ID: 21734239
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes.
Aury-Landas J; Bazille C; Allas L; Bouhout S; Chesneau C; Leclercq S; Boumédiene K; Baugé C
Sci Rep; 2017 Jul; 7(1):6483. PubMed ID: 28744016
[TBL] [Abstract][Full Text] [Related]
27. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
[TBL] [Abstract][Full Text] [Related]
28. PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
Cui B; Yang Q; Guan H; Shi B; Hou P; Ji M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E962-70. PubMed ID: 24512488
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.
Avan A; Crea F; Paolicchi E; Funel N; Galvani E; Marquez VE; Honeywell RJ; Danesi R; Peters GJ; Giovannetti E
Mol Cancer Ther; 2012 Aug; 11(8):1735-46. PubMed ID: 22622284
[TBL] [Abstract][Full Text] [Related]
30. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells.
Liu TP; Lo HL; Wei LS; Hsiao HH; Yang PM
Anticancer Drugs; 2015 Feb; 26(2):139-47. PubMed ID: 25203626
[TBL] [Abstract][Full Text] [Related]
31. Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche.
Gaudichon J; Milano F; Cahu J; DaCosta L; Martens AC; Renoir JM; Sola B
PLoS One; 2014; 9(9):e107009. PubMed ID: 25255316
[TBL] [Abstract][Full Text] [Related]
32. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.
Zhang P; Yang X; Ma X; Ingram DR; Lazar AJ; Torres KE; Pollock RE
Mol Cancer; 2015 Mar; 14():55. PubMed ID: 25890085
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
[TBL] [Abstract][Full Text] [Related]
35. Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
Uchiyama N; Tanaka Y; Kawamoto T
Eur J Pharmacol; 2017 Oct; 812():138-146. PubMed ID: 28705714
[TBL] [Abstract][Full Text] [Related]
36. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
[TBL] [Abstract][Full Text] [Related]
37. 3-Deazaneplanocin A suppresses aggressive phenotype-related gene expression in an oral squamous cell carcinoma cell line.
Hatta M; Naganuma K; Kato K; Yamazaki J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):269-73. PubMed ID: 26505792
[TBL] [Abstract][Full Text] [Related]
38. DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice.
Zheng S; Xiao L; Liu Y; Wang Y; Cheng L; Zhang J; Yan N; Chen D
Cell Death Dis; 2018 Feb; 9(3):310. PubMed ID: 29472543
[TBL] [Abstract][Full Text] [Related]
39. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.
Zoabi M; Sadeh R; de Bie P; Marquez VE; Ciechanover A
Biochem Biophys Res Commun; 2011 May; 408(3):393-8. PubMed ID: 21513699
[TBL] [Abstract][Full Text] [Related]
40. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
